AutoGenomics in the News
- FDA Approves First Test to Help Identify Elevated Risk of Developing Opioid Use Disorder December 20, 2023 - Dec. 19, 2023 The following is attributed to Jeff Shuren, M.D., J.D., director of the FDA's Center for Devices and Radiological Health Today, the U.S. Food and Drug Administration approved the first test that uses DNA in assessing whether certain individuals may have an elevated risk of developing opioid use disorder (OUD). As part of… read more